ABVC BioPharma, Inc. (ABVC)
0.8171
+0.02
(+2.69%)
USD |
NASDAQ |
Aug 28, 16:00
0.8171
0.00 (0.00%)
After-Hours: 17:48
ABVC BioPharma Cash from Operations (Quarterly) : -0.2444M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2444M |
| March 31, 2026 | -0.8942M |
| December 31, 2025 | -0.5876M |
| September 30, 2025 | -0.9647M |
| June 30, 2025 | -0.8942M |
| March 31, 2025 | -0.5398M |
| December 31, 2024 | -0.2475M |
| September 30, 2024 | 0.0602M |
| June 30, 2024 | -0.2114M |
| March 31, 2024 | -0.9558M |
| December 31, 2023 | -0.5862M |
| September 30, 2023 | -0.8604M |
| June 30, 2023 | -0.8672M |
| March 31, 2023 | -1.873M |
| December 31, 2022 | -0.6425M |
| September 30, 2022 | -0.4913M |
| June 30, 2022 | -3.453M |
| March 31, 2022 | -3.052M |
| December 31, 2021 | |
| September 30, 2021 | -2.859M |
| June 30, 2021 | -1.447M |
| March 31, 2021 | -1.415M |
| December 31, 2020 | -4.226M |
| September 30, 2020 | 0.3267M |
| June 30, 2020 | -1.443M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.6997M |
| December 31, 2019 | -1.684M |
| September 30, 2019 | -0.444M |
| June 30, 2019 | -0.5689M |
| March 31, 2019 | -0.6114M |
| December 31, 2018 | -1.087M |
| September 30, 2018 | -0.2164M |
| June 30, 2018 | -0.3524M |
| March 31, 2018 | -0.5995M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | -0.2249M |
| September 30, 2016 | -0.2114M |
| June 30, 2016 | -2.834M |
| March 31, 2016 | 0.4454M |
| December 31, 2015 | -0.8743M |
| September 30, 2015 | -0.0031M |
| June 30, 2015 | 0.0023M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0056M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.684M |
| Perspective Therapeutics, Inc. | -20.65M |
| MiMedx Group, Inc. | -10.03M |
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | 17.45M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.1015M |
| Cash from Financing (Quarterly) | 0.2262M |
| Free Cash Flow | -2.697M |
| Free Cash Flow Per Share (Quarterly) | -0.0094 |
| Free Cash Flow to Equity (Quarterly) | -0.4006M |
| Free Cash Flow to Firm (Quarterly) | -0.2021M |
| Free Cash Flow Yield | -13.23% |